A study to assess the role of CognitiveBotics software (Artificial Intelligence based software) in the management of Autism Spectrum Disorder.
- Conditions
- Health Condition 1: F840- Autistic disorder
- Registration Number
- CTRI/2023/06/054257
- Lead Sponsor
- CognitiveBotics Technologies Private Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. Children diagnosed ASD using assessment scales such as
Childhood Autism Rating Scales (CARS)
2. Children with 2 to 18 years
3. Children with associated comorbidities will be included as long as the child is able to use the tool.
4. Ability to understand and respond to instructions given in English
5. Access to a device on which the software can be accessed using internet connection.
6. Parents who have consented for their child to use the software.
1. Children with intellectual disability with IQ score <50.
2. Parents who are not willing to consent to the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Ability to use the software & follow online instructions by the child & parents <br/ ><br>2. Ability to log childâ??s day to day progress automatically and provide visual graphical feedback on the dashboard <br/ ><br>3. Ability to measure the efficacy of the software, <br/ ><br>a. The childâ??s performance captured by the software at baseline T1 and at T2 <br/ ><br>b. We are comparing to proxy gold standard Clinical scales given below for progress at T1 and T2 <br/ ><br>i. Childhood Autism Rating Scale (CARS), <br/ ><br>ii. ATEC Autism Treatment Evaluation Checklist <br/ ><br>iii. VB MAPP <br/ ><br>c. Parent ILP checklist â?? at baseline T1 and end of the study T2Timepoint: Throughout the study
- Secondary Outcome Measures
Name Time Method â?¢To examine if the increase in the number of hours spent on the tool is corelated to the changes in the scores of the scales at T1 & T2.Timepoint: Throughout the study